Baseline Serum Interleukin-6 Levels Predict the Response of Patients with Advanced Non-small Cell Lung Cancer to PD-1/PD-L1 Inhibitors

Although various studies on predictive markers in the use of PD-1/PD-L1 inhibitors are in progress, only PD-L1 expression levels in tumor tissues are currently used. In the present study, we investigated whether baseline serum levels of IL-6 can predict the treatment response of patients with advanc...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Immune Netw
Prif Awduron: Kang, Da Hyun, Park, Cheol-Kyu, Chung, Chaeuk, Oh, In-Jae, Kim, Young-Chul, Park, Dongil, Kim, Jinhyun, Kwon, Gye Cheol, Kwon, Insun, Sun, Pureum, Shin, Eui-Cheol, Lee, Jeong Eun
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: The Korean Association of Immunologists 2020
Pynciau:
Brief Communication
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7327149/
https://ncbi.nlm.nih.gov/pubmed/32655975
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4110/in.2020.20.e27
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg